KAIZEN-MD.COM
  • Welcome
  • COVID-19 Immune Booster
    • Course of Illness
    • Lung Disease
    • Immune Defense

Better Today. Better Tomorrow.
KAIZEN-MD

COVID-19: Lung Disease and Hypoxia


Identification of HYPOXIA (oxygen saturation levels below 94%) in the "Early Pulmonary Phase" of COVID-19 is a critical point in early intervention.
Picture
Early control of inflammatory response is critical in Early Pulmonary Phase.
Source: Eastern Virginia Medical School COVID Care Protocol
Picture
Picture
Picture
Picture
Picture
Picture

Based on CT findings and lung biopsy, HYPOXIA in the "Early Pulmonary Phase" may be due to early formation of microvascular clots in the lungs.
Picture
Picture
Picture
Picture
Picture

Lung Damage from COVID-19 May Be Irreversible
Picture
Picture
Picture
​


Prevention and treatment should include dietary supplements that are rich in anti-oxidants and anticoagulation properties in order to reduce pulmonary severity along with cardiovascular, circulatory, and neurologic complications from various infectious disease including COVID-19. 


Welcome
COVID-19 Pandemic Update
Course of Illness
Supplements
Site powered by Weebly. Managed by FatCow
  • Welcome
  • COVID-19 Immune Booster
    • Course of Illness
    • Lung Disease
    • Immune Defense